Paragraph 1
For the purposes of ensuring consistent compliance with the licensing conditions prescribed in Schedule 1 , the Authority shall give directions under section 23(1) (conduct of licensed activities) of the 2004 Act, as applied by regulation 6, specifying—
the serious adverse events or serious adverse reactions that must be notified to the Authority, including the time period for such notification;
the data, or type of data, that must be kept to ensure the traceability of organs;
how long information on organ and donor characterisation must be kept for;
the medical activities, or the types of medical activities, that must be performed under the advice and guidance of a registered medical practitioner;
the F1... international and national legislation and standards on the sterilisation of medical devices which shall be complied with (and the guidelines on the sterilisation of medical devices which shall be taken into account) in respect of procurement material and equipment which could affect the quality and safety of an organ, or the health of the donor or recipient; and
the adequate facilities and equipment that should be used for organ and donor characterisation.
Annotations
Textual amendments
- F1
Words in Sch. 2 para. 1(e) omitted (31.12.2020) by virtue of The Quality and Safety of Organs Intended for Transplantation (Amendment) (EU Exit) Regulations 2019 (S.I. 2019/483), regs. 1, 3(14)(a); 2020 c. 1, Sch. 5 para. 1(1)